Abridge AI
Latest round
- Series E
Last raised
- Jun 2025
Total raised
- $765M
Investors
- 26
About Abridge AI
Based in the US, Abridge AI, Inc. specializes in generative AI technology that transforms clinical conversations into actionable, billable notes, enhancing the efficiency of healthcare providers and improving patient outcomes. Founded in 2018, Abridge AI, Inc. operates from its headquarters in Pittsburgh, US, focusing on innovative healthcare documentation solutions. The founders Shiv Rao (CEO), Florian Metze, and Sandeep Konam have collectively contributed to the company's growth. In June 2026, Abridge AI, Inc. Abridge specializes in advanced generative AI technology tailored for clinical conversations, transforming patient-clinician interactions into contextually aware, clinically useful, and billable AI-generated notes. The Abridge Contextual Reasoning Engine streamlines clinical documentation by capturing conversation essences in real-time, significantly reducing clinicians’ cognitive load and enhancing patient care. Their solutions serve a diverse clientele, including healthcare leaders such as Johns Hopkins, Kaiser Permanente, Duke Health, and the Mayo Clinic, improving clinician efficiency and patient outcomes across various settings. Abridge's products integrate seamlessly into existing workflows and support multilingual environments within the United States market, allowing healthcare professionals to focus more on patient care instead of administrative tasks. Abridge generates revenue through enterprise-grade AI solutions structured as subscription-based models, enabling healthcare organizations to access its innovative clinical documentation technology. Major healthcare providers partner with Abridge to utilize its services, aimed at increasing documentation compliance and closing revenue cycle gaps. The pricing model reflects service value with tailored plans for different healthcare systems. Abridge's flagship offerings enhance operational performance and facilitate accurate capture of billable services in real-time, fostering a collaborative environment with healthcare organizations.
Who invested in Abridge AI
26 investors across 7 rounds
See all investors in Abridge AI
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series E
Jun 12, 2025
Amount
$316M
Investors
Series D
Nov 14, 2024
Amount
$250M
Investors
Series C
Feb 22, 2024
Amount
$141M
Investors
Series B
Oct 26, 2023
Amount
$30M
Investors
Series A
Aug 11, 2022
Amount
$13M
Investors
Series A
Oct 6, 2020
Amount
$10M
Investors
Seed
Feb 15, 2019
Amount
$5M
Investors
Questions about Abridge AI
Who invested in Abridge AI?
Abridge AI has 26 investors on record across 7 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Abridge AI raised?
Abridge AI has raised 7 venture rounds. Sign up free to see how much each round raised and the total.
When did Abridge AI last raise money?
Abridge AI's most recent round on record is a Series E, in Jun 2025.
What does Abridge AI do?
Based in the US, Abridge AI, Inc.
Where is Abridge AI headquartered?
Abridge AI is headquartered in Philadelphia, US.
Which VCs invest in companies like Abridge AI?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare it companies at Abridge AI's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series E
Raising like Abridge AI? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.